PREVALENCE OF BETA(2)-GLYCOPROTEIN-I ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS WITH BETA(2)-GLYCOPROTEIN-I DEPENDENT ANTIPHOSPHOLIPID ANTIBODIES
J. Matsuda et al., PREVALENCE OF BETA(2)-GLYCOPROTEIN-I ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS WITH BETA(2)-GLYCOPROTEIN-I DEPENDENT ANTIPHOSPHOLIPID ANTIBODIES, Annals of the Rheumatic Diseases, 54(1), 1995, pp. 73-75
Objective-To investigate whether beta(2)-glyceprotein I antibody (aGPI
) exists in sera that are positive for antiphospholipid antibodies (aP
L). Methods-Thirty six patients with systemic lupus erythematosus (SLE
) and 20 healthy volunteers were recruited. GPI independent and depend
ent aPL (anticardiolipin (aCL), antiphosphatidylserine, antiphosphatid
ylinositel, antiphosphatidic acid) were measured using a conventional
enzyme Linked immunosorbent assay (ELISA). aGPI was measured by an ELI
SA using a gamma irradiated plate coated with purified GPI. Results-Tw
enty of 36 SLE patients were positive for at least one of the GPI-depe
ndent aPL. Five of these 20 were also positive for aGPI. Another five
of the 20 showed low GPI dependency aCL antibodies; however, three of
these patients required GPI for binding to phosphatidylserine, phospha
tidylinositol, or both. Conclusion-We confirmed the existence of aGPI
in patients with true GPI dependent aPL. From these results, we recomm
end the use of a gamma irradiated plate with GPI as antigen for the de
tection of phosphate true GPI dependent aPL or aGPI. microlitres